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Abstract 
Three aspartic proteases (SVAPs) have been isolated from venom of the saw-scaled viper, Echis ocellatus. In 
confirmation of prior transcriptomic predictions, all three forms match to sequences of either of the two SVAP 
transcripts (EOC00051 and EOC00123), have a molecular weight of 42 kDa and possess a single N-glycan. The 
SVAPs act in a renin-like manner, specifically cleaving human and porcine angiotensinogen into angiotensin-1 
and possess no general protease activity. Their activity is completely inhibited by the aspartyl protease 
inhibitor Pepstatin A. 
 
    In a previous study we presented evidence for the existence of renin-like aspartic proteases in the venom 
gland transcriptome of the West African (Nigeria) saw-scaled viper, Echis ocellatus (Wagstaff and Harrison, 
2006). This was the first report of this protein group being expressed in snakes. Full-length sequences of two 
aspartic proteases were determined, EOC00051 [AM180265] and EOC00123 [AM180266], and in both the 
presence of a signal peptide sequence was identified. This, and the absence of lysosomal targeting sequences, 
strongly indicated that these proteases would be secreted components of venom. Analysis of the two sequences 
also revealed >50% overall sequence identity with human (P00797) and mouse (P06281) renin-1, including 
conserved cysteine patterns and catalytic residues. Our evidence thus suggested that aspartic proteases with 
renin-like activity may be E. ocellatus venom components and therefore function as a new class of venom 
toxins. Here we outline the results of further studies carried out to isolate these proteases from the venom and 
confirm their renin-like activity.  
A) Confirmation of Aspartic Proteases in venom of E. ocellatus 
To detect aspartic proteases in venom, we first generated a polyclonal antibody specific to E. ocellatus venom 
aspartic proteases (SVAP) by immunizing a rabbit with a multi-antigenic RYDSSESSTYKPKGT peptide 
immunogen: this peptide corresponds to residues 122-136 of both translated transcripts, EOC00051 and 
EOC00123. This antibody reacted with a band at approximately 42 kDa in immunoblots of E. ocellatus (i) whole 
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venom and (ii) gel filtration chromatography (GFC)-separated venom proteins (data not shown). This band was 
evident on Coomassie blue-stained venom SDS-PAGE gels (at a level estimated to be equivalent to around 2% 
of total venom protein as predicted by our transcriptional data) and was excised and subjected to in-gel trypsin 
digestion for mass analysis. Nine of the resultant peptides matched sequences of the original SVAP transcripts 
(Table 1, column WV). In addition to these matching peptide masses, we obtained the sequence of the tryptic 
peptide GFFSQDIVR (res 149-157) by ES-MS-MS. This venom proteomic data clearly confirmed that the 
protein[s] contained in this band matched to the transcripts EOC00123 and EOC00051 in the E. ocellatus 
transcriptome. 
B) Isolation of three isoforms of Venom Aspartic Proteases 
     Following identification of the 42 kDa band as the putative SVAP, we set out to isolate sufficient amounts of 
the purified protein for function analysis. Fifty mg of E. ocellatus (Nigeria) venom in 5 mL PBS (50 mM sodium 
phosphate, 150 mM NaCl, pH 7.2) was subjected to gel filtration chromatography (GFC) on a 90 cm x 2.6 cm 
Superdex 200 column. Elution was carried out at 2.0 mL/min. The putative SVAP (42 kDa band on SDS-PAGE) 
was partially purified by this chromatographic procedure, eluting just after the 65 kDa venom 
metalloproteases. Further purification was carried out using anion exchange chromatography on a 1 mL Mono 
Q column (GE Healthcare), eluting with a 0 - 0.3 M gradient of NaCl in 50 mM Tris-Cl, pH 7.8. Multiple peaks 
were routinely detected for the SVAPs using this separation method, providing evidence for at least three main 
isoforms, which we designated SVAP B1, SVAP A1 and SVAP B2 (in order of elution from Mono Q) based on 
their sequence matches to the transcripts (EOC00051 = form A; EOC00123 = form B, see Table 1). A third 
chromatography step was carried out in order to acquire highly purified samples of SVAP A1, SVAP B1 and 
SVAP B2 isoforms. Mono Q fractions containing both SVAP A1 and SVAP B1 were loaded onto a 1 mL Phenyl 
Superose hydrophobic interaction chromatography (HIC) column (GE Healthcare) equilibrated in 50 mM Tris-
Cl, 3 M NaCl, pH 7.8 and eluted with a gradient of decreasing NaCl concentration. The two isoforms A1 and B1  
were fully separated from each other using HIC. SVAP B2 was also further purified on HIC during which it 
chromatographed as a single peak.  SDS-PAGE analysis of three purified isoforms (Fig. 1A) reveals that SVAP A1 
has a slightly lower molecular mass than that of SVAP B1 and SVAP B2. Multiple bands can be seen for each 
isoform suggesting further structural variation within each isoform. This variation may be due to the presence 
of glycoforms: all three isoforms ran with higher mobility on SDS-PAGE following overnight treatment with 
PNGase F to remove N-glycans; the apparent mwt decreased by Ca. 4 kDa, suggesting a single N-glycan (data 
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Table 1.  Peptide mass matches from the MALDI-TOF spectrum of peptides obtained through in-gel 
digestion of 42 kDa bands from SDS-PAGE gels of whole venom [WV], or following digestion of 
isolated SVAP isoforms AI, B1 and B2.  
Mass (Da) Peptide WV A1 B1 B2 
3309.6 HSESNTGGEIILGGSDPSHYTGDFHYVSTSR Y    
3190.6 VVFDTGSSNLWVPSHQCSPLYSACVSHNR Y    Y    Y 
2274.3 ITLTYGQGYIEGFLSQDIVR Y    Y    Y 
2032.1 DTQYYGEISIGTPAQIFK Y    
1819.1 QAIGGVIPVFDNIMSEK Y    
1664.0 VVFDTGSSNLWVPSR  Y    Y   
1562.9 VLSENVFSVYYSR Y    Y   Y Y 
1315.8 GPLWLLGATFIK Y    Y Y 
1068.5 GFFSQDIVR Y    Y   
Sequences were obtained from the theoretical digest tool (http://ca.expasy.org/tools/peptide-mass.html). 
Double-underlined sequences (═) are unique to EOC00051, single-underlined sequences (─) are unique to 
EOC00123 and sequences possessing no underlining are common to both isoforms . 
 
not shown). Both transcript sequences have a single potential N-glycosylation site at residue 64. Using trypsin 
digestion and mass spectrometry [MS] analysis to isolate and identify peptides unique to either of the two 
transcripts, we were able to confirm that SVAP A1 is derived from EOC00051, whereas SVAP B1 and SVAP B2 
are derived from transcript EOC00123 (Table 1). 
C) Confirmation of the renin-like function of Venom Aspartic Proteases 
Since SVAP B1 was routinely found to be the most abundant of the three isoforms in E. ocellatus venom, this 
protein was used to develop the assay for renin-like activity. The assay incubation mixture contained the  
tetradecapeptide substrate, human angiotensinogen (DRVYIHPFHLVIHN; at a concentration of 100 ug/mL in 
PBS) with SVAP B1 at 10 ug/mL and was incubated at 37ºC for 1-20 hours. MS was used to analyse the 
decapeptide (angiotensin-1, M+H+ 1296.0) and tetrapeptide (VIHN, M+H+ 482.3) products arising from renin-
like cleavage between residues 10 and 11. Although direct analysis for angiotensin-1 on MALDI-TOF provided a 
rapid measure of renin-like activity, a C18 reverse-phase HPLC separation of substrate and products along with 
subsequent MALDI-MS or ESI-MS analysis of the peaks allowed for a semi-quantitative measure of activity and 
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Fig. 1. A SDS-PAGE  analysis of isolated SVAP isoforms. Each of the three main SVAP isoforms (lanes B1, 
A1, B2) were checked for purity on a 12% polyacrylamide gel. The samples have not been adjusted to equalise 
concentration prior to loading, so the staining intensity gives an approximate indication of the relative 
quantities of each isoform in the venom. The gels were silver stained according to the method of Heukeshoven 
and Dernick (1985). Lane S, molecular weight standards, from top to bottom are 67, 45, 37, 29, 24, 20 and 14 
kDa. Each band contains 15 ng of protein. B RP-HPLC and MS analysis of renin assay substrates and 
products. Various combinations of SVAP B1 (10 ug/mL), human angiotensinogen (100 ug/mL) were 
incubated in PBS at 37ºC for 4 hours. The reaction was stopped with 0.5% (v/v) TFA and peptides were 
separated with a 20 minute, 0-65% gradient of acetonitrile in 0.1% TFA. Isolated substrate/products were 
analysed by MS and the M+H+ values found are shown next to the relevant peak. Lower trace is 
angiotensinogen control; upper trace is SVAP + angiotensinogen. C. Analysis of the general proteolytic 
activity of SVAP B1. Various combinations of SVAP B1 (10 ug/mL), alpha casein, beta casein (100 ug/mL) 
and GFC-isolated metalloprotease (20 ug/mL) were incubated in PBS at 37ºC for 4 hours. Ten uL samples of 
each incubation mixture were loaded onto a 15% polyacrylamide gel and subsequently stained with 
Coomassie Blue R250. Lane 1 alpha casein alone; lane 2, beta casein alone; lane 3, SVAP B1 alone; lane 4, 
alpha casein incubated with SVAP B1; lane 5, beta casein incubated with SVAP B1; lane 6, alpha and beta 
casein(mixed) incubated with metalloprotease; lane S, molecular weight standards, from top to bottom are 
67, 45, 37, 29, 24, 20 and 14 kDa. 
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a more complete analysis of the specificity of SVAP B1 towards the substrate (example, Fig. 1B). The results of 
all these analyses confirmed the renin-like specificity of SVAP B1. Thus, we identified (by both mass and 
sequence) the presence of the tetrapeptide product VIHN which hadn’t been detectable using MALDI-MS. The 
presence of this peptide product provided evidence for a specific cleavage event rather than the possibility of a 
carboxypeptidase-like activity of the SVAP being responsible for the generation of angiotensin-1 from 
angiotensinogen. Under the conditions used here, conversion was typically 70-80% complete within 3 hours. 
This activity was almost completely inhibited by the aspartyl protease inhibitor, Pepstatin A, at a concentration 
of 10 uM, but was not inhibited by the serine or metalloproteinase inhibitors, PMSF or EDTA. All three isoforms 
were shown to be active towards human angiotensinogen and to be inhibited by 10 uM Pepstatin A. These 
analyses were successfully repeated using porcine angiotensinogen (DRVYIHPFHLLVYS). 
     Using a lower purity SVAP fraction from the anion exchange separation, and with prolonged assay times 
with human angiotensinogen we were able to detect small quantities of products with M+H+ values of 551, 552, 
763 and 1226. These are likely to be the angiotensinogen fragments RVYI, DRVY, IHPFL and IHPFLVIHN 
respectively and are probably present due to the action of minor quantities of other venom proteases, 
emphasising the need for the HIC separation step for full purification of the SVAPs. 
    Purified SVAP B1 was tested for general protease activity by incubating it at 10 ug/mL with 100 ug/mL alpha 
or beta casein. GFC-isolated metalloprotease from the same venom batch was used as a positive control. Using 
the same conditions required to convert 80%+ of angiotensinogen to angiotensin-1, SVAP B1 appeared to have 
no proteolytic activity towards the two caseins (Fig. 1C). In contrast, the metalloprotease brought about a 
complete loss of the alpha casein band and a partial digestion of beta casein.  
   The data presented here confirms the presence in E. ocellatus venom of the aspartic proteases predicted from 
our transcriptional studies (Wagstaff and Harrison, 2006) and that these possess the postulated renin-like 
activity. In this previous paper we discussed the possibility that entry of venom aspartic proteases into the 
vasculature might be expected to induce local hypertension, which may compound SVMP-induced tissue 
damage, but also systemic hypertension. However, we can find no evidence in the literature for systemic 
hypertension following E. ocellatus envenomation, although such effects may be masked by the complex and 
rapid pathology associated with viper venom-induced haemorrhage. Indeed, there are very few studies in 
which hypertension has been demonstrated in the pathology of envenoming by any snake species. In the few 
cases reporting hypertension symptomology following envenoming by Vipera berus berus (Malina et al., 2008); 
Proatheris superciliari (Valenta et al., 2008); Bitis nasicornis (Malina and Krecsak 2008) and Naja haje (Omran 
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and AbdelNabi 1997), hypertension was not attributed to a specific venom component. Where a component of 
the venom has been indicated as being responsible for hypertension, it was thought to act indirectly e.g. 
through metalloprotease-induced activation of inactive renin in B. arietans (see Morris and Taylor, 1987). Thus, 
this study is the first in which a venom component has been isolated that may be directly responsible for 
hypertensive effects of envenomation.  
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